ArticleYonsei medical journal2020

Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study.

Minkyung Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.